ALTO NEUROSCIENCE INC (ANRO) Stock Balance Sheet
USA - NYSE:ANRO - US02157Q1094 - Common Stock
13.64 USD
-0.56 (-3.94%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 147.59M | 168.23M | 82.55M | 48.34M | 25.70M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | null | null | null | null | null | |||
| Receivables | null | 30.00K | 112.00K | 546.00K | 1.74M | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 2.26M | 1.08M | 2.73M | 330.00K | 236.00K | |||
| Total Current Assets | 149.85M | 169.34M | 85.39M | 49.22M | 27.68M | |||
| Non-Current Assets | ||||||||
| PPE Net | 6.96M | 7.70M | 1.23M | 1.58M | 1.06M | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | null | null | |||
| Other Non-Current Assets | 1.07M | 504.00K | 6.00K | 55.00K | 50.00K | |||
| Total Non-Current Assets | 8.03M | 8.21M | 1.24M | 1.63M | 1.11M | |||
| TOTAL ASSETS | 157.88M | 177.54M | 86.63M | 50.85M | 28.79M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | null | null | null | null | null | |||
| Accrued Expenses | 6.46M | 8.43M | 4.54M | 3.95M | 1.21M | |||
| Accounts Payable | 1.67M | 1.58M | 1.07M | 1.61M | 600.00K | |||
| Other Current Liabilities | null | null | null | null | null | |||
| Total Current Liabilities | 8.13M | 10.01M | 5.61M | 5.56M | 1.81M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 22.12M | 11.56M | 9.86M | 9.46M | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 4.21M | 4.52M | 1.35M | 2.00M | 1.30M | |||
| Total Non-Current Liabilities | 26.34M | 16.07M | 11.21M | 11.46M | 1.30M | |||
| TOTAL LIABILITIES | 34.47M | 26.08M | 16.82M | 17.02M | 3.11M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -171.27M | -138.40M | -76.97M | -40.66M | -12.95M | |||
| Additional Paid In Capital | 294.65M | 289.95M | 5.37M | 2.30M | 494.00K | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 3.00K | 3.00K | 141.48M | 72.23M | 38.16M | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | 31.00K | -101.00K | -81.60K | -46.00K | -22.00K | |||
| Shares Outstanding | 27.07M | 26.99M | 25.57M | 25.57M | 25.57M | |||
| Tangible Book Value per Share | 4.5587 | 5.6123 | -2.8025 | -1.5018 | -0.4879 | |||
| Total Shareholders' Equity | 123.41M | 151.46M | 69.81M | 33.83M | 25.68M | |||
| TOTAL LIABILITIES AND EQUITY | 157.88M | 177.54M | 86.63M | 50.85M | 28.79M | |||
| Statistics | ||||||||
| Debt/Equity | 0.18 | 0.08 | 0.14 | 0.28 | N/A | |||
| Current Ratio | 18.43 | 16.92 | 15.22 | 8.85 | 15.30 | |||
| Return On Assets (ROA) | -41.08% | -34.60% | -41.91% | -54.49% | -31.91% | |||
| Return On Equity (ROE) | -52.55% | -40.56% | -52.01% | -81.91% | -35.77% | |||
All data in USD , ROIC based on taxRate of 0.21